Consolidated Statement of Shareholders' Equity (Deficit) - USD ($) $ in Thousands |
Total |
Cumulative Effect Period Of Adoption Adjustment [Member] |
Cumulative Effect Period Of Adoption Adjusted Balance [Member] |
Series P2 Convertible Preferred Stock [Member] |
Previously Reported [Member] |
Preferred Stock [Member]
Convertible Preferred Stock [Member]
Cumulative Effect Period Of Adoption Adjustment [Member]
|
Preferred Stock [Member]
Previously Reported [Member]
Convertible Preferred Stock [Member]
|
Common Stock [Member] |
Common Stock [Member]
Cumulative Effect Period Of Adoption Adjustment [Member]
|
Common Stock [Member]
Cumulative Effect Period Of Adoption Adjusted Balance [Member]
|
Common Stock [Member]
Series P2 Convertible Preferred Stock [Member]
|
Common Stock [Member]
Previously Reported [Member]
|
Additional Paid in Capital [Member] |
Additional Paid in Capital [Member]
Cumulative Effect Period Of Adoption Adjustment [Member]
|
Additional Paid in Capital [Member]
Cumulative Effect Period Of Adoption Adjusted Balance [Member]
|
Additional Paid in Capital [Member]
Series P2 Convertible Preferred Stock [Member]
|
Additional Paid in Capital [Member]
Previously Reported [Member]
|
Accumulated Deficit [Member] |
Accumulated Deficit [Member]
Cumulative Effect Period Of Adoption Adjusted Balance [Member]
|
Accumulated Deficit [Member]
Previously Reported [Member]
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beginning balance at Dec. 31, 2019 | $ 129,921 | $ 2,978 | $ (126,943) | $ (129,921) | $ 129,921 | $ (53) | $ 6 | $ 59 | $ 129,974 | $ 170,600 | $ 40,626 | $ (167,628) | $ (167,628) | |||||||
Beginning balance, Shares at Dec. 31, 2019 | (153,758,348) | 153,758,348 | (1,992,064) | 63,204,426 | 65,196,490 | |||||||||||||||
Issuance of common stock upon exercise of stock options | $ 66 | $ 1 | $ 65 | |||||||||||||||||
Issuance of common stock upon exercise of stock options, Shares | 5,318,139 | 5,318,139 | ||||||||||||||||||
Vesting of early exercised stock options | $ 21 | 21 | ||||||||||||||||||
Issuance of series P-2 Preferred stock Number of shares issued | 27,989,240 | |||||||||||||||||||
Issuance of Series P-2 convertible preferred stock | $ 63,932 | $ 3 | $ 63,929 | |||||||||||||||||
Repurchase of unvested restricted common stock, Shares | (3,230) | |||||||||||||||||||
Conversion of promissory notes to Series P-2 convertible preferred stock | $ 8,203 | $ 8,203 | ||||||||||||||||||
Conversion of promissory notes to Series P-2 convertible preferred stock, Shares | 3,507,984 | |||||||||||||||||||
Stock-based compensation | 666 | 666 | ||||||||||||||||||
Net loss | (39,650) | $ (39,650) | ||||||||||||||||||
Ending balance at Dec. 31, 2020 | $ 36,216 | $ 10 | 243,484 | (207,278) | ||||||||||||||||
Ending balance, Shares at Dec. 31, 2020 | 100,016,559 | 100,016,559 | ||||||||||||||||||
Issuance of common stock upon exercise of stock options | $ 62 | 62 | ||||||||||||||||||
Issuance of common stock upon exercise of stock options, Shares | 2,180,168 | 2,180,168 | ||||||||||||||||||
Vesting of early exercised stock options | $ 111 | 111 | ||||||||||||||||||
Repurchase of unvested restricted common stock, Shares | (433,359) | |||||||||||||||||||
Issuance of Series D convertible preferred stock upon exercise of warrants | 20,877 | 20,877 | ||||||||||||||||||
Issuance of Series D convertible preferred stock upon exercise of warrants, Shares | 2,020,034 | |||||||||||||||||||
Business combination, net of redemptions and equity issuance costs and PIPE financing, net | 300,745 | $ 4 | 300,741 | |||||||||||||||||
Business combination, net of redemptions and equity issuance costs and PIPE financing, net, Shares | 41,249,985 | |||||||||||||||||||
Issuance of common stock upon exercise of common stock warrants, value | 82,546 | $ 1 | 82,545 | |||||||||||||||||
Issuance of common stock upon exercise of common stock warrants, shares | 7,177,885 | |||||||||||||||||||
Vesting of restricted stock units | 61,015 | |||||||||||||||||||
Stock-based compensation | 11,434 | 11,434 | ||||||||||||||||||
Net loss | (125,874) | (125,874) | ||||||||||||||||||
Ending balance at Jan. 02, 2022 | $ 326,117 | $ 15 | $ 659,254 | $ (333,152) | ||||||||||||||||
Ending balance, Shares at Jan. 02, 2022 | 152,272,287 | 152,272,287 |
X | ||||||||||
- Definition Business combination, net of redemptions and equity issuance costs. No definition available.
|
X | ||||||||||
- Definition Business combination net of redemptions and equity issuance costs, shares No definition available.
|
X | ||||||||||
- Definition Issuance of common stock upon exercise of common stock warrants, shares No definition available.
|
X | ||||||||||
- Definition Issuance of common stock upon exercise of common stock warrants, value No definition available.
|
X | ||||||||||
- Definition Repurchase Of Unvested Restricted Common Stock Shares No definition available.
|
X | ||||||||||
- Definition Stock Issued During Period Exercise of warrants No definition available.
|
X | ||||||||||
- Definition Stock Issued During Period Exercise Of Warrants Shares No definition available.
|
X | ||||||||||
- Definition Stock Issued During Period Vesting Of Early Exercised Stock Options No definition available.
|
X | ||||||||||
- Definition Vesting of restricted stock units No definition available.
|
X | ||||||||||
- Definition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares issued during the period as a result of the conversion of convertible securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The gross value of stock issued during the period upon the conversion of convertible securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Value of stock issued as a result of the exercise of stock options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|